Table 1.
Bladder cancer incidence and mortality.
| https://gco.iarc.fr/today/home | Estimated number of new cases in 2020 | Estimated number of deaths in 2020 | Mortality Rate (%) | Crude Mortality Rate (per 100,000) | ASR (World) (per 100,000) | |
|---|---|---|---|---|---|---|
| Worldwide | All | 573,278 | 212,536 | 37.1 | 2.7 | 1.9 |
| Male | 440,864 | 158,785 | 36.0 | 4.0 | 3.3 | |
| Female | 132,414 | 53,751 | 40.6 | 1.4 | 0.9 | |
| Europe | All | 203,983 | 67,289 | 33.0 | 9.0 | 3.0 |
| Male | 156,658 | 50,816 | 32.4 | 14.1 | 5.5 | |
| Female | 47,325 | 16,473 | 34.8 | 4.3 | 1.2 | |
| North America | All | 89,997 | 21,045 | 23.4 | 5.7 | 2.1 |
| Male | 69,080 | 15,129 | 21.9 | 8.3 | 3.5 | |
| Female | 20,917 | 5,916 | 28.3 | 3.2 | 1.1 | |
Estimated number of new cases of bladder cancer 2020, worldwide, Europe and North America.
ASR, age-standardised rates.